Agilent Oncology Research Summit 2026
When: 03 November 2026
Time: 14:00 - 16:00 CET
Format: Live virtual event
As oncology research continues to evolve, researchers are looking for ways to connect technologies, streamline workflows, and generate deeper biological insights. Join us for Day 2 of the Agilent Oncology Research Summit and explore approaches that bring together cell analysis, genomics, and laboratory workflows to support cancer research. Through expert presentations and interactive discussions, attendees will gain perspectives on emerging technologies and applications that are helping accelerate research and support future discoveries.
Why Attend?
From understanding cellular behavior to exploring molecular mechanisms, today's oncology research relies on multiple technologies working together to answer increasingly complex scientific questions.
This virtual event will explore approaches that help researchers connect different stages of the research workflow, enabling more efficient and integrated research strategies.
Whether your work focuses on cell biology, molecular biology, genomics, or translational research, the session will provide valuable perspectives on technologies and trends shaping oncology research.
Event Format
Live Presentations: Insights, applications, and perspectives from experts across oncology research.
Interactive Q&A: Opportunities to engage directly with speakers during the live event.
Virtual Booth: Access educational content, scientific resources, and technology information.
On-Demand Recording: Available to registered attendees following the event.
Explore our speaker lineup and discover the innovative topics that will be featured throughout the summit, including:
Learn more about our expert speakers and the presentations they will be delivering.
Continue the Conversation Beyond the Auditorium
The virtual booth will provide access to additional resources and opportunities to learn more about technologies supporting oncology research.
Explore
Visit the virtual booth before, during, and after the presentations to make the most of your event experience.
For research use only. Not for use in diagnostic procedures.
PR7005-2293
Please fill out the form to register in our event for day #2
Connecting Technologies Across the Research Workflow
Cheryl C. Tan, Ph.D.
Field Application Scientist, Genomics at Agilent
This presentation highlights the benefits of a targeted approach to transcriptome profiling and introduces the Somatic Transcriptome Panel and its integrated bioinformatics solution, developed in collaboration with Dartmouth Hitchcock Medical Center. We will explore how capture-based RNA sequencing, Magnis automation, and a comprehensive analysis and reporting platform work together to deliver a streamlined, end-to-end sample-to-report workflow.
About the speaker
Cheryl Tan is a Genomics Field Applications Scientist at Agilent with a PhD in Biological Sciences and MB(ASCP) certification. Before joining Agilent, she spent several years working as an applications scientist supporting advanced molecular profiling platforms in fields such as cancer and immuno-oncology.
Matt Wang,
Sr. Product Manager at Agilent
The Magnis NGS Prep System is a closed system that fully automates NGS Library Preparation and Target Enrichment with Agilent SureSelect Reagents
About the speaker
Matt Wang is a Senior Product Manager for the Magnis NGS Prep System, where he leads product strategy for system architecture, workflow integration, and global commercial deployment. Matt brings hands-on experience in FDA medical device compliance, clinical LDT verification and validation, and LIMS integration and cybersecurity requirements.
Danielle Fletcher,
Field Application Scientist,Bioinformatics at Agilent
Comprehensive genomic profiling often requires flexibility to address specific research needs and areas of interest. This presentation will introduce Agilent SureSelect Cancer CGP panels, before exploring how SureDesign can be used to create customised SureSelect panels. Through a live demonstration, we will walk through the process of translating targets of interest into a tailored panel design, highlighting key considerations along the way.
About the speaker
Danielle Fletcher is a Field Application Scientist at Agilent Technologies, supporting customers with NGS and genomic applications. A key part of her role is helping customers design and customize Agilent solutions for their specific genomic applications and workflows.
Charles W. Amirmansour, Ph. D.
Global Commercial Competency Lead at Agilent
Cancer cells are not static. They continually adapt their metabolism, morphology, interactions with the surrounding microenvironment and responses to therapeutic pressure. Understanding these behaviours requires more than a single measurement or analytical perspective.
In this presentation, Dr Charles William Amirmansour will explore how complementary cell-analysis approaches can help researchers move from complex biological observations towards more actionable insight. The session will examine how real-time metabolic analysis, live-cell imaging, microplate-based detection and flow cytometry can provide different but connected views of cancer cell function, treatment response and cell-to-cell variability.
Rather than focusing on any one technology in isolation, the presentation will highlight the value of combining orthogonal measurements to build a more complete understanding of cancer biology. Attendees will see how integrated functional insights can help reveal changes that might otherwise be missed, strengthen confidence in experimental interpretation and support the development of more biologically relevant cancer-research workflows.
About the speaker
Dr. Amirmansour leads Global Business Development in Agilent Technologies’ Cell and Biomolecular Analysis Division. Across 25 years in research, product strategy and commercial leadership, he has helped academic and biopharma laboratories achieve reproducible, data-driven results.
A trained pharmacologist, he earned a BSc (Hons) from King’s College London and a doctorate in Clinical Pharmacology from University College London, followed by postdoctoral fellowships at Imperial College London and the Harefield Heart Science Centre.
He now applies hisexpertise in microplate, imaging, liquid handling and high-content workflows through global seminars and masterclasses on assay design, automation and scientific storytelling.